Latest News

IPO Report: Sagimet Biosciences gives going public a second chance under new CEO

Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday. 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News